Affiliation:
1. Department of Pharmacy, School of Medical and Allied Sciences, Galgotias University, Greater Noida, Uttar Pradesh, India
Abstract
Abstract:
The COVID-19 illness is a highly contagious disease presently affecting more than 200
countries caused by the SARS-CoV-2 coronavirus (Severe Acute Respiratory Syndrome
Coronavirus-2). Persons with diabetes mellitus (DM), severe obesity, cardiovascular disease, and
hypertension are more likely to be infected with COVID-19 and are at a higher risk of death. The
COVID-19 pandemic is overlapping the preexisting diabetes pandemic to produce fast and very
vulnerable groups of COVID-19 and diabetes patients. Evidence relating to COVID-19 and
diabetes is less but continues to emerge. In this context, we present evidence identified through
rapid reviews. The current manuscript aims to provide information on diabetic patients suffering
from COVID-19. Consequently, diabetic people have a higher susceptibility to severe SARS-CoV-
2 infections since defects in the glucose metabolism exacerbate the COVID-19 pathogenesis. After
an extensive literature survey, it can come to an end that specific care is required for diabetes
patients suffering from the COVID-19 virus. COVID-19 infection in diabetic patients may lead to
loss of life if immediate care is not taken. This paper gives insight into the COVID-19 disease
complications relevant to diabetes and emphasizes the current information and emerging concepts
for SARS-CoV-2 infections in patients with DM.
Publisher
Bentham Science Publishers Ltd.
Subject
Immunology and Allergy,Endocrinology, Diabetes and Metabolism